Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Spinal Cord Injury · Traumatic Spinal Cord Injury · Paraplegia and Tetraplegia · Metabolic Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Kessler Institute for Rehabilitation, West Orange, New Jersey, United States
Contact: Study coordinator (Trevor Dyson-Hudson, MD) · tdysonhudson@kesslerfoundation.org · 917-838-3143James Wilson, DO (Sub-investigator)Chris Cirnigliaro, PhD (Sub-investigator)Contact: Principal Investigator (Trevor Dyson-Hudson, MD)Northwell Health, Manhasset, New York, United States
Contact: Principal Investigator (Ona Bloom, PhD)Adam B Stein, MD (Sub-investigator)James J. Peters VA Medical Center, The Bronx, New York, United States
Contact: Principal Investigator (Jill Wecht, EdD)